Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aptargroup Inc ATR

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and... see more

Recent & Breaking News (NYSE:ATR)

Aptar Named One of "America's Most Responsible Companies 2020" by Newsweek

Business Wire January 31, 2020

Aptar Declares Quarterly Dividend

Business Wire January 16, 2020

Aptar Announces Quarterly Conference Call and Annual Meeting Information

Business Wire January 2, 2020

Aptar Reports Third Quarter Results; Acquires Noble International, a Leader in Drug Delivery Training Devices and Patient Onboarding; Announces Segment Leadership Appointments

Business Wire October 31, 2019

Aptar Opens New Technical Education Center Focused on Training and Retaining Manufacturing Talent

Business Wire October 23, 2019

Aptar's Activ-Blister(TM) Packaging Solution Approved by U.S. FDA for Oral Solid Dose HIV Prevention Medicine

Business Wire October 22, 2019

Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

PR Newswire October 21, 2019

Aptar Declares Quarterly Dividend

Business Wire October 17, 2019

Aptar Joins Catalyst CEO Champions For Change to Accelerate the Progress and Representation of Women in its Global Workforce

Business Wire October 9, 2019

Aptar to Acquire a Strategic Equity Interest in BTY, a Leading Chinese Color Cosmetics Packaging Manufacturer

Business Wire October 7, 2019

Biohaven Advances NOJECTION(TM) Migraine Platform With Completion Of Enrollment Of Pivotal Phase 2/3 Trial Of Vazegepant, The First Intranasally Administered CGRP Receptor Antagonist In Development For The Acute Treatment Of Migraine

PR Newswire September 10, 2019

Aptar Enters into Strategic Partnership with PureCycle to Accelerate Integration of Ultra-Pure Recycled Polypropylene into Dispensing Solutions

Business Wire September 3, 2019

Aptar Announces Partnership with TerraCycle's Loop Platform

Business Wire August 29, 2019

Aptar Partners with Nippon Closures to Provide Innovative Tethered Beverage Closure Solutions

Business Wire August 26, 2019

Aptar Announces Capital Markets Day and Confirms Third Quarter Conference Call Date

Business Wire August 22, 2019

Aptar Reports Second Quarter Results

Business Wire July 31, 2019

Aptar's Nasal Unidose Device Approved by US FDA for First Needle-Free Rescue Treatment for Severe Hypoglycemia

Business Wire July 25, 2019

Aptar Declares Quarterly Dividend

Business Wire July 17, 2019

Aptar Releases Corporate Sustainability Report

Business Wire May 30, 2019

Aptar Joins the Ellen MacArthur Foundation's CE100 Circular Economy Network

Business Wire May 23, 2019